+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd Edition)

  • ID: 4035515
  • Report
  • Region: Global
  • 36 Pages
  • Industry Standard Research (ISR)
1 of 4

A biosimilars boom is expected and both biopharma and contract manufacturers want to be positioned to capture a piece of the market. The Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd edition) goes into depth on one of the most important aspects of biosimilars: manufacturing. Manufacturing these complex products in a cost efficient manner will be a critical component to successfully commercializing biosimilars and the anticipated boom. Outsourced manufacturing decision-makers share their perspectives on selling and manufacturing biosimilars, how much biosimilar manufacturing is expected to be outsourced, comfort levels in outsourcing to particular CMOs and the key challenges associated with the manufacture of biosimilars.

What You Will Learn:

  • Understand The Motivations For Selling And/Or Manufacturing Biosimilars And Biobetters
  • Primary Drivers For Outsourcing Biosimilar Manufacturing And Perceived Challenges In Biosimilar Manufacturing
  • Get An Early Indication Of Market Leaders By Knowing Which Contract Manufacturers Respondents Would Be Most Compfortable Using For Biosimilar Production

How You Can Use This Report:

  • Identify Peer-Trusted Cmos To Shortlist For Outsourced Biosimilar Manufacturing Projects
  • Understand Where, Geographically, Biopharmaceutical Companies Are Looking To Manufacture Biosimilars
  • Gain Insight Into The Characteristics Sponsors Value From A Cmo And Leverage These Attributes In Sales And Marketing Efforts
Note: Product cover images may vary from those shown
2 of 4

1. Introduction

2. Methodology

3. Respondent Qualifications 

  • Participant Geoography
  • Paticipant Company Size

4. Prologue

  • Large Molecule Product Offering
  • Large Vs Small Molecule Outsourcing

5. Study Data 

  • Large Molecule Manufacturing
  • Stance On Selling Biosimilars
  • Motivations For Selling Biosimilars Based Off Own Large Molecule Products-Unprompted
  • Biosimilars Vs Biobetters
  • Stance On Manufacturing Biosimilars
  • Comparison Of Selling Vs Manufacturing Biosimilars
  • Bioprocessing Equipment
  • Outsourced Biosimilars Manufacturing Activities
  • Primary Biosimilar Outsourcing Drivers
  • Biosimilar Manufacturing By Geography
  • Biosimilar Outsourcing Comfort
  • Most Difficult Aspect Of Biosimilar Manufacturing-Unprompted

6. Demographics 

  • Company Type
  • Decision-Making Responsibility
  • Outsourcing Inuence
  • Job Title
  • Involvement In Outsourced Manufacturing
  • Headquarters Location
  • Office Location
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4035515